robinul glycopyrronium bromide (glycopyrrolate) 0.2mg/1ml injection ampoule
aspen pharmacare australia pty ltd - glycopyrronium bromide, quantity: 0.2 mg/ml - injection, solution - excipient ingredients: water for injections; sodium hydroxide; sodium chloride; hydrochloric acid - 1.as a preoperative antimuscarinic to reduce salivary, tracheobronchial and pharyngeal secretions, and to reduce the acidity and volume of the gastric contents. 2.as a preoperative or intraoperative antimuscarinic to attenuate or prevent intraoperative bradycardia associated with the use of suxa-methonium or due to cardiac vagal reflexes. 3.to protect against the peripheral muscarinic actions (eg. bradycardia and excessive secretions) of anticholinesterases such as neostigmine or pyridostigmine given to reverse neuromuscular blockade produced by nondepolarising muscle relaxants.
seebri breezhaler glycopyrronium (as bromide) 50 microgram powder for inhalation (in capsule) blister
novartis pharmaceuticals australia pty ltd - glycopyrronium bromide, quantity: 63 microgram (equivalent: glycopyrronium, qty 50 microgram) - inhalation, powder for - excipient ingredients: hypromellose; carrageenan; potassium chloride; magnesium stearate; purified water; sunset yellow fcf; lactose monohydrate; strong ammonia solution; ethanol absolute; propylene glycol; potassium hydroxide; butan-1-ol; shellac; iron oxide black; isopropyl alcohol - seebri breezhaler is indicated as a once-daily maintenance bronchodilator treatment to relieve symptoms of patients with chronic obstructive pulmonary disease (copd).
glycopyrronium bromide 200mcg/ml solution for injection
macarthys laboratories limited - glycopyrronium bromide - solution for injection - glycopyrronium bromide 200 microgram(s)/millilitre - drugs for functional gastrointestinal disorders
glycopyrronium bromide 200mcgs/ml solution for injection
central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - glycopyrronium bromide - solution for injection - glycopyrronium bromide 200 µg/ml - drugs for functional gastrointestinal disorders
glycopyrronium bromide 200micrograms/ml solution for injection
central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - glycopyrronium bromide - solution for injection - glycopyrronium bromide 200 µg/ml - drugs for functional gastrointestinal disorders
glycopyrronium bromide 200 micrograms per ml solution for injection
central procurement & supplies unit ub002 industrial estate, san gwann sgn 3000, malta - glycopyrronium bromide - solution for injection - glycopyrronium bromide 200 µg/ml - drugs for functional gastrointestinal disorders
glycopyrronium bromide 200 micrograms per ml solution for injection
health house pharma ltd t/as p&d pharmaceuticals ltd 38 woolmer way, bordon, hampshire, gu35 9q, united kingdom - glycopyrronium bromide - solution for injection - glycopyrronium bromide 200 µg/ml - drugs for functional gastrointestinal disorders
glycopyrronium bromide solution for injection 200 mcg
martindale pharma, united kingdom - glycopyrronium bromide - solution for injection - 200 mcg
glycopyrronium bromide and neostigmine metilsulfate 0.5mg/2.5mg per ml
boucher & muir (nz) ltd t/a mercury pharma (nz) - glycopyrronium bromide 0.5 mg/ml; neostigmine metilsulfate 2.5 mg/ml - solution for injection - active: glycopyrronium bromide 0.5 mg/ml neostigmine metilsulfate 2.5 mg/ml excipient: citric acid citric acid monohydrate dibasic sodium phosphate dodecahydrate sodium hydroxide water for injection - reversal of residual non-depolarising (competitive) neuromuscular block.
brimica genuair 340/12 aclidinium bromide and formoterol fumarate dihydrate powder for inhalation dry powder inhaler
a menarini australia pty ltd - aclidinium bromide, quantity: 0.4 mg/actuation; formoterol fumarate dihydrate, quantity: 0.012 mg/actuation - inhalation, powder for - excipient ingredients: lactose monohydrate - brimica genuair 340/12 is indicated as a long-term twice daily maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (copd).